scholarly journals Copy number aberration analysis to predict response to neoadjuvant anti-HER2 therapy: results from the NeoALTTO phase III clinical trial.

2021 ◽  
pp. clincanres.1317.2021
Author(s):  
David Venet ◽  
Mattia Rediti ◽  
Marion Maetens ◽  
Debora Fumagalli ◽  
David N. Brown ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Copy Number ◽  
Copy Number Aberration ◽  
Phase Iii ◽  
Phase Iii Clinical Trial

scholarly journals P2.05-006 Credentialing of Radiotherapy Centres in Australasia for a Phase III Clinical Trial on SABR (TROG 09.02 CHISEL)

2017 ◽  
Vol 12 (11) ◽  
pp. S2405-S2406
Author(s):  
T. Kron ◽  
B. Chesson ◽  
N. Hardcastle ◽  
M. Burns ◽  
M. Crain ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Iii ◽  
Phase Iii Clinical Trial

Industry Watch

2007 ◽  
Vol 11 (22) ◽  
pp. 1468-1482
Keyword(s):  
Clinical Trial ◽  
Stem Cell ◽  
Tamil Nadu ◽  
Point Of Care ◽  
Opioid Therapy ◽  
Phase Iii ◽  
Cancer Drugs ◽  
Phase Iii Clinical Trial ◽  
Chinese Academy Of Sciences ◽  
Academy Of Sciences

Arana Therapeutics Completes Project with CSL. Biotech Capital to Invest $2.2 Million in Generic Health Pty Ltd. Phase III Clinical Trial for “Dual Opioid” Therapy. Beijing Med-Pharm Announces Exclusive Agreement to Market Enablex in China. Genesis Pharmaceuticals Collaborates with the Institute of Microbiology, Chinese Academy of Sciences. NPIL and Merck Collaborate on Cancer Drugs. LifeCell Launches First Stem Cell Center in Tamil Nadu. Japan's Bioventures Today — BCS, Inc. Bio-Rad Launches In2it A1C Analyzer for Point-Of-Care Diabetes Testing.

Sign in / Sign up

Export Citation Format

Share Document